Viibryd vs. Drizalma Sprinkle

• Are Viibryd and Drizalma Sprinkle the Same Thing?
• What Are Possible Side Effects of Viibryd?
• What Are Possible Side Effects of Drizalma Sprinkle?
• What Is Viibryd?
• What Is Drizalma Sprinkle?
• What Drugs Interact with Viibryd?
• What Drugs Interact with Drizalma Sprinkle?
• How Should Viibryd Be Taken?
• How Should Drizalma Sprinkle Be Taken?

Viibryd (vilazodone hydrochloride) and Drizalma Sprinkle (duloxetine delayed-release capsules) and are antidepressants used to treat depression.

Drizalma Sprinkle is also used to treat generalized anxiety disorder in adults and pediatric patients ages 7 years to 17 years old, diabetic peripheral neuropathic pain in adults, and chronic musculoskeletal pain in adults.

Viibryd and Drizalma Sprinkle are different types of antidepressants. Drizalma Sprinkle is a serotonin and norepinephrine reuptake inhibitor (SNRI) and Viibryd is a selective serotonin reuptake inhibitor (SSRI).

Side effects of Viibryd and Drizalma Sprinkle that are similar include nausea.

Side effects of Viibryd that are different from Drizalma Sprinkle include dry mouth, drowsiness, constipation, decreased appetite, and increased sweating.

Side effects of Drizalma Sprinkle that are different from Viibryd include diarrhea, vomiting, and sleep problems (insomnia).

Both Viibryd and Drizalma Sprinkle may interact with alcohol, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, other antidepressants, migraine headache medicines, blood thinners, St. John's wort, fentanyl, and tramadol.

Viibryd may also interact with other drugs that make you sleepy or slow your breathing (sleeping pills, narcotics, prescription cough medicines, muscle relaxers, or medicines for anxiety or seizures), diuretics (water pills), mephenytoin, medicines to treat ADHD or narcolepsy, and medicines to treat anxiety, mood disorders, thought disorders, or mental illness.

Drizalma Sprinkle may also interact with monoamine oxidase inhibitors (MAOIs), lithium, tryptophan, buspirone, amphetamines, cimetidine, ciprofloxacin, enoxacin, quinidine, phenothiazines, type 1C antiarrhythmics, aluminum-and magnesium-containing antacids, famotidine, proton pump inhibitors (PPIs), theophylline, caffeine, centrally acting CNS drugs, and highly plasma protein binding drugs.

Common side effects of Viibryd include:

• increased or excessive sweating,
• dizziness,
• drowsiness,
• dry mouth,
• constipation,
• sleep problems (insomnia),
• loss of appetite,
• tightness in your jaw,
• nausea,
• weight loss,
• blurred vision,
• nervousness,
• decreased sex drive,
• impotence, or
• difficulty having an orgasm.

Common side effects of Drizalma Sprinkle include:

• nausea,
• dry mouth,
• drowsiness,
• constipation,
• decreased appetite, and
• increased sweating

Viibryd (desvenlafaxine) is type of antidepressant called a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder.

Drizalma Sprinkle (duloxetine delayed-release capsules) is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for major depressive disorder in adults, generalized anxiety disorder in adults and pediatric patients ages 7 years to 17 years old, diabetic peripheral neuropathic pain in adults, and chronic musculoskeletal pain in adults.

Viibryd may interact with cold or allergy medicines, sedatives, narcotics, sleeping pills, muscle relaxers, medicines for seizures or anxiety, other antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDs), blood thinners, St. John's wort, tramadol, L-tryptophan, heart medications, or medicines to treat migraines.

Viibryd may also interact with diuretics (water pills), linezolid, lithium, metoclopramide, midazolam, antibiotics, antifungals, blood pressure medications, or HIV/AIDS medicines.

Drizalma Sprinkle may interact with monoamine oxidase inhibitors (MAOIs), triptans, tricyclic antidepressants, other SNRIs or SSRIs, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, St. John's wort, cimetidine, ciprofloxacin, enoxacin, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, warfarin, quinidine, phenothiazines, type 1C antiarrhythmics, aluminum-and magnesium-containing antacids, famotidine, proton pump inhibitors (PPIs), theophylline, caffeine, centrally acting CNS drugs, highly plasma protein binding drugs, and alcohol. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Drizalma Sprinkle; third trimester use may increase risk of symptoms of poor adaptation (respiratory distress, temperature instability, feeding difficulty, low muscle tone, tremor, irritability) in newborns. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. Drizalma Sprinkle passes into breast milk but its effects on nursing infants are unknown. Consult your doctor before breastfeeding.

The recommended dose for Viibryd is 50 mg once daily, with or without food.

The dose of Drizalma Sprinkle is 60 mg daily for most conditions.